Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 2:46 AM
Ignite Modification Date: 2025-12-26 @ 1:26 AM
NCT ID: NCT03725033
Description: None
Frequency Threshold: 0
Time Frame: During the study - 12 weeks.
Study: NCT03725033
Study Brief: Clinical Trial of Efficacy and Safety of Subetta in the Treatment of Impaired Glucose Tolerance
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Subetta Tablet for oral use. 2 tablets twice daily. The tablets should be held in mouth until completely dissolved 15 min prior to meal. 0 None 0 105 15 105 View
Placebo Tablet for oral use. 2 tablets twice daily. The tablets should be held in mouth until completely dissolved 15 min prior to meal. 0 None 0 97 20 97 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Pain in the abdomen SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA View
Epigastric pain SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA View
Vomiting SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA View
Urinary tract infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA View
Acute respiratory tract infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA View
Acute bronchitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA View
Acute conjunctivitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA View
Acute cystitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA View
Rhinitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA View
Rhinopharyngitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA View
Increase of leukocytes in the urine SYSTEMATIC_ASSESSMENT Investigations MedDRA View
Increase of alanine aminotransferase levels SYSTEMATIC_ASSESSMENT Investigations MedDRA View
Increase of aspartate aminotransferase level SYSTEMATIC_ASSESSMENT Investigations MedDRA View
Increase of glycated hemoglobin level SYSTEMATIC_ASSESSMENT Investigations MedDRA View
Increase of blood pressure SYSTEMATIC_ASSESSMENT Investigations MedDRA View
Weight loss SYSTEMATIC_ASSESSMENT Investigations MedDRA View
Postprandial hyperglycemia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA View
Diabetes mellitus SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA View
Epistaxis SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA View
Arthralgia SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA View
Back pain SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA View
Deterioration of the condition SYSTEMATIC_ASSESSMENT General disorders MedDRA View
Unsteadiness of gait SYSTEMATIC_ASSESSMENT General disorders MedDRA View
Concussion of the brain SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA View
Soft tissue injury SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA View